AxoGen (AXGN) Tops Q2 EPS by 6c, provides guidance

AxoGen (NASDAQ: AXGN) reported Q2 EPS of $0.12, $0.06 better than the analyst estimate of $0.06. Revenue for the quarter came in at $56.66 million versus the consensus estimate of $52.66 million.

GUIDANCE:

AxoGen sees FY2025 revenue of $219 million, versus the consensus of $216.18 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.4 calls to 1 put on 1.2M contracts as share price up 4%
• Kushner: conversations between U.S. and different areas of Iran govt are more robust than it has every been
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance